Severe Allergic Reactions to Indian Medications Make Headlines
Emergency Import of Fibrinogen
Amin Afshar, Chairman of the Board of the Iranian Hemophilia Society, stated:
Due to the failure to return plasma-derived products to the country, the Food and Drug Administration has come under pressure and was forced to request emergency imports of fibrinogen from India. As a result of using this imported fibrinogen from Indian warehouses, many patients have experienced respiratory disorders and severe allergic reactions.
On the other hand, due to poor health oversight in pharmaceutical production in India, continuing this approach may lead to the spread of bloodborne viruses, as occurred during the 1970s and 1980s.
Unfortunately, the system is dysfunctional, and certain individuals are exploiting this lack of governance and disorder. Oversight of this process falls under the Food and Drug Administration, but this organization neither monitors the plasma import process nor ensures its return to the country, and it fails to refer the involved companies to the judiciary for accountability.
